Salud financiera de hoja de balance de Mangalam Drugs & Organics
Salud financiera controles de criterios 3/6
Mangalam Drugs & Organics tiene un patrimonio de accionistas total de ₹1.4B y una deuda total de ₹964.5M, lo que sitúa su ratio deuda-patrimonio en 71%. Sus activos y pasivos totales son ₹3.3B y ₹2.0B respectivamente. El BAIT de Mangalam Drugs & Organics es de ₹27.5M, por lo que su ratio de cobertura de intereses es de 0.2. Tiene efectivo e inversiones a corto plazo que ascienden a ₹9.1M.
Información clave
71.0%
Ratio deuda-patrimonio
₹964.49m
Deuda
| Ratio de cobertura de intereses | 0.2x |
| Efectivo | ₹9.11m |
| Patrimonio | ₹1.36b |
| Total pasivo | ₹1.98b |
| Activos totales | ₹3.33b |
Actualizaciones recientes sobre salud financiera
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29
These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01
Recent updates
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors
Aug 13A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
May 23Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹2.3B) de MANGALAM superan a sus pasivos a corto plazo (₹2.1B).
Pasivo a largo plazo: Los activos a corto plazo de MANGALAM (₹2.3B) superan a sus pasivos a largo plazo (₹391.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MANGALAM (70.4%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de MANGALAM ha crecido de 59.2% a 71.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de MANGALAM está bien cubierta por el flujo de caja operativo (41%).
Cobertura de intereses: Los pagos de intereses de la deuda de MANGALAM no están bien cubiertos por el BAIT (0.2x cobertura).